AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors
Journal of Chemical Information and Modeling · 2024
DOI: 10.1021/acs.jcim.4c01110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2024. Verfasst von Ioannis Gkekas und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki 57001, Greece. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Antiviral Agents, Angiotensin-Converting Enzyme 2. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Secretariat for Research and Innovation, European Regional Development Fund, Operational Programme Competitiveness, Entrepreneurship and Innovation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki 57001, Greece.
- Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki 57001, Greece.
- Institute of Chemical Biology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, Athens 11635, Greece.
- Laboratory of Biology, Department of Medicine, Democritus University of Thrace, Alexandroupolis 68100, Greece.
- Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.
- Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens 11635, Greece.
ORCID-Profile: Ioannis Gkekas, Sotirios Katsamakas, Stelios Mylonas, Theano Fotopoulou, George Ε Magoulas, Marios Dimitriou, Apostolos Axenopoulos, Nafsika Rossopoulou, Theodora Katsila, Maria Koufaki, Theodora Calogeropoulou, Petros Daras, Spyros Petrakis
Förderung
- General Secretariat for Research and Innovation
- European Regional Development Fund
- Operational Programme Competitiveness, Entrepreneurship and Innovation
- Ministry of Development and Investment
Zitieren
APA
Gkekas, I., Katsamakas, S., Mylonas, S., Fotopoulou, T., Magoulas, G. Ε., Tenchiu, A. C., Dimitriou, M., Axenopoulos, A., Rossopoulou, N., Kostova, S., Wanker, E. E., Katsila, T., Papahatjis, D., Gorgoulis, V. G., Koufaki, M., Karakasiliotis, I., Calogeropoulou, T., Daras, P., & Petrakis, S. (2024). AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.4c01110
Vancouver
Gkekas I, Katsamakas S, Mylonas S, Fotopoulou T, Magoulas GΕ, Tenchiu AC, et al. AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors. Journal of Chemical Information and Modeling. 2024. doi:10.1021/acs.jcim.4c01110
BibTeX
@article{Gkekas2024,
author = {Gkekas, Ioannis and Katsamakas, Sotirios and Mylonas, Stelios and Fotopoulou, Theano and Magoulas, George Ε and Tenchiu, Alia Cristina and Dimitriou, Marios and Axenopoulos, Apostolos and Rossopoulou, Nafsika and Kostova, Simona and Wanker, Erich E and Katsila, Theodora and Papahatjis, Demetris and Gorgoulis, Vassilis G and Koufaki, Maria and Karakasiliotis, Ioannis and Calogeropoulou, Theodora and Daras, Petros and Petrakis, Spyros},
title = {AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors},
journal = {Journal of Chemical Information and Modeling},
year = {2024},
doi = {10.1021/acs.jcim.4c01110}
}
EUVIMED